Ellex Medical Lasers Limited (ELX), a global leader in ophthalmic laser and ultrasound technology, announced that it will expand its presence in the ophthalmic diagnostics market through a strategic partnership with leading medical device manufacturer CenterVue SpA.
Effective 4 October 2010, Ellex has entered into an exclusive distribution agreement with Italian-based CenterVue to market and distribute the MAIATM fundus perimetry system in the United States and Australia. Designed for the diagnosis of retinal disease, MAIATM complements Ellex’s existing range ofophthalmic treatment lasers and will open up new market segments for the Company in both the United States and Australia.
“Maia provides essential technology to Ellex’s target customers, and the product fits well with our existing sales, marketing and service capabilities,” commented Simon Luscombe, Ellex CEO. “It also complements our breakthrough Retinal Regeneration Therapy (Ellex 2RTTM) for the treatment of retinal disease.”
MAIATM is a new-generation fundus perimetry system that accurately measures macular sensitivity, fixation stability and the point of fixation – important for the diagnosis of macular health and retinal disease. The system also features a Scanning Laser Ophthalmoscope (SLO) in order to capture clear images of the retina. MAIATM adds another market leading technology to Ellex’s growing third-party distribution business, which generated revenues of approximately $7 million in the 2010 financial year over and above sales of the Company’s proprietary products and technologies. Under the terms of the agreement Ellex will leverage its existing direct sales and distribution channels to sell the MAIATM system in the United States and Australia. This new product addition is expected to significantly increase the Company’s market share in the ophthalmic diagnostics market and contribute to sales revenue during the 2011 financial year.
Ellex Medical Lasers Limited (ELX) is a global leader in the design and manufacture of ophthalmic laser and ultrasound systems used by ophthalmologists to diagnose and treat eye disease. In recent years, Ellex has diversified its product range beyond lasers and ultrasound equipment to include a number of third-party ophthalmic products. CenterVue SpA is a profitable, Italian-based medical device manufacturer dedicated to developing new technologies to aid the early detection of many diseases. Collectively, the CenterVue team has more than 90 years’ experience in the ophthalmic industry, and includes an in-house research team. CenterVue introduced the MAIATM microperimetry system in 2009 for the diagnosis of retinal disease and in 2010 received approval from the US Food and Drug Administration (FDA) to market the device in the United States.
http://www.traderdealer.com.au/Fundamentals/elx
Tags: Ellex Medical Lasers, ELX, Healthcare, New contract
